Integrative Analysis of Disease Signatures Shows Inflammation Disrupts Juvenile Experience-Dependent Cortical

Milo R Smith1, Poromendro Burman2, Masato Sadahiro3

  • 1Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York 10029; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York 10029; Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York 10029; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029; Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York 10029; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029.

Eneuro
|January 20, 2017
PubMed

Insights

Inflammation disrupts critical developmental brain plasticity in juveniles, impacting neurodevelopmental disorders. Targeting inflammation may offer new prevention and intervention strategies for conditions like autism.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Immunology

Background:

  • Neuroplasticity is crucial for brain development during childhood and adolescence.
  • Neurodevelopmental disorders like autism are common, necessitating identification of plasticity disruptors.
  • Inflammation is implicated as a potential disruptor of developmental plasticity.

Purpose of the Study:

  • To identify common pathological processes disrupting neuroplasticity signatures.
  • To investigate the role of inflammation in disrupting developmental cortical plasticity in vivo.
  • To explore potential therapeutic targets for neurodevelopmental disorders.

Main Methods:

  • A novel computational approach linked 436 transcriptional disease signatures with neuroplasticity signatures.
  • The mouse ocular dominance model was used to assess experience-dependent plasticity in the primary visual cortex.
  • Systemic lipopolysaccharide administration was used to induce inflammation in juvenile mice.

Main Results:

  • Inflammation was identified as a common pathological process linked to disrupted plasticity signatures.
  • Systemic inflammation suppressed cortical plasticity during the juvenile critical period.
  • Inflammation induced specific transcriptional changes in molecular regulators within the primary visual cortex.

Conclusions:

  • Inflammation poses unrecognized risks to postnatal brain development and plasticity.
  • Targeting inflammation may be a viable strategy to mitigate the impact of neurodevelopmental disorders.
  • Findings highlight the link between inflammation, neuroplasticity, and neurodevelopmental outcomes.